The healthspan revolution is good for business.
Long game. UBS projects global longevity spending will reach $8T annually by 2030, driven by medical progress, aging populations, and shifting consumer behavior.
From life sciences to consumer wellness, rising life expectancy and the pursuit of better health are poised to transform the economy.
Healthcare & biotech. GLP-1s alone could surpass $200B in annual sales this decade. Alzheimer’s, cardiovascular, and cancer treatments are opening multi-billion-dollar opportunities, with AI accelerating diagnostics and drug discovery.
Consumer health & nutrition. Prevention is overtaking treatment as functional foods, supplements, and performance products fuel everyday demand for vitality and metabolic health.
Beauty x longevity. Anti-aging is evolving into “inside-out” optimization. From ingestibles to skin health, consumers are investing in products that deliver recovery, cognition, and resilience, not just appearance.
Lifestyle & finance. Wellness real estate, senior living, and community-based models are expanding. The new nest egg, financial services must adapt to a “100-year life,” with rising demand for retirement, healthcare coverage, and wealth solutions.
Takeaway: Longevity is a powerful growth engine, and the companies that harness its momentum will define how we live, age, and thrive.
